Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-25-007107
Filing Date
2025-11-06
Accepted
2025-11-06 18:13:46
Documents
1
Period of Report
2025-11-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7418
  Complete submission text file 0001171843-25-007107.txt   8990
Mailing Address 100 SPY COURT MARKHAM Ontario, Canada
Business Address 100 SPY COURT MARKHAM Ontario, Canada (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM Ontario, Canada
Business Address
Nijhawan Pardeep (Reporting) CIK: 0001777962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 251459895